The present exploratory study evaluated serum concentrations of galectins-1, 3 and 9 for the first time in LTX recipients, with and without BOS, and in healthy controls to assess their potential role as clinical biomarkers. Here, LGALS1 is linked to Buschke-Ollendorff syndrome.